ICU (SeaStar Medical Holding Corporation) Company Net Income

Official company branding of seastarmedical.com (ICU)

The strategic goal of SeaStar Medical Holding (ICU) is the implementation of automated blood purification systems to reduce the workload of intensive care personnel. The company's profit history demonstrates progress in this direction, where the metric value stands at -0.01. However, barriers remain in the form of the complexity of combating organ failure through innovative cytopheresis and the specifics of direct B2B equipment supplies to US pediatric clinics.

SeaStar Medical Holding Corporation (ICU) Net Income: for the period 04/28/2023 - 11/01/2026

Financial and market metric breakdowns for SeaStar Medical (ICU)

- current price and projected stock value:
Quote Chart SeaStar Medical Holding Corp.|ICU - Analyst Consensus Forecast
- business market valuation indicators:
Market Value SeaStar Medical Holding Corp.|ICU - Real Price to Acquire Entire Company
- balance sheet equity data:
Book Value per Share SeaStar Medical|ICU - Company Net Assets|Market Cap to Book Value Multiple seastarmedical.com|ICU - Company Total Assets
- debt and solvency information:
Total Debt to Capital Coefficient SeaStar Medical Holding|ICU - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio SeaStar Medical Holding Corporation|ICU - Company Total Debt|Debt to Net Assets Ratio SeaStar Medical Holding Corp.|ICU - Company Long-Term Debt|Company Current Liabilities SeaStar Medical|Immediate Liquidity seastarmedical.com
- earnings and market multiples details:
ICU - Net Profit
Summary company analysis:SeaStar Medical Holding Corp. (ICU)
Mass-produced product of SeaStar Medical Holding Corp

Business resilience to market shocks is determined by the ability to generate cash flow, which is confirmed by the unique FDA status for pediatric cytoapheresis held by SeaStar Medical Holding (ICU). By analyzing the company's current earnings, an investor assesses the gap between financial reporting and market capitalization, where a steady upward trend in the indicator signals sustained investment potential and the effectiveness of the issuer's niche dominance.

Main competitors

Profit After Tax DXCM (Dexcom CGM)|PEN (Penumbra, Inc.) - Net Profit|Company Net Income novanta.com NOVT|Net Income HAE (Haemonetics)|Net Profit Inspire Medical (INSP)|PROCEPT BioRobotics Inc - Net Income|Profit After Payment of Taxes CNMD (CONMED Inc.)|Pulse Biosciences, Inc. - Net Profit|Net Financial Result inmodemd.com INMD|PMI: Net Profit|Net Income Surmodics Inc|Net Income SENS|NPCE: Final Profit|Company Net Income Tactile Systems Technology (TCMD)|Net Income sanuwave.com SNWV|Net Profit OM (Outset Medical)|SmartVest (ELMD) - Company Net Income|LENSAR, Inc - Net Profit|RCEL (AVITA Medical Inc) - Company Profit|PROF: Net Profit|BDMD - Net Financial Result|EDAP (EDAP TMS SA) - Net Profit|Net Income Bovie Medical (APYX)|Net Profit ICCM|Net Profit pulmonx.com (LUNG)|Company Net Income TELA Bio TELA|CytoSorbents Corp - Company Net Income|SRTS: Net Income|Final Profit ZYXI (Zynex Medical)|ECOR: Net Profit|Company Net Income Vicarious Surgical (RBOT)|Company Net Income Inspira Technologies Oxy B.H.N. Ltd.|IRIX - Annual Net Income|Net Income INBS (Intelligent Bio Solutions)|Net Profit beyondair.net (XAIR)|Net Profit PFSA (Profusa, Inc.)|Net Financial Result STRATA Skin Sciences Inc. (SSKN)|GCTK - Company Net Income|Profit After Tax NAOV|Venus Concept (VERO) - Company Net Income|Net Income Nuwellis Inc|AEMD (Aethlon) - Net Profit|Company Net Income TransEnterix ASXC|Company Net Income Avinger, Inc. (AVGR)|BioSig - Company Profit|Cutera - Net Income|Profit After Payment of Taxes KNW (Know Labs Inc)|NARI - Company Net Income|Net Financial Result Nevro Medical NVRO|RSLS: Net Profit|Company Net Income silkroadmed.com (SILK)